Disc Medicine, INC Form 4 insider transactions

Director William Richard White sold shares of Disc Medicine (IRON) on July 1, 2024, under a pre-arranged 10b5-1 trading plan.

Director Kevin Bitterman reports acquiring Disc Medicine shares and a potential liability for short-swing profits due to a matchable purchase with prior sales by related entities.

Director Mona Ashiya reports indirect purchases of Disc Medicine (IRON) common stock through affiliated entities.

OrbiMed Advisors LLC and related entities report the acquisition of Disc Medicine, Inc. (IRON) common stock through a series of transactions on June 17, 2024.

AI DMI LLC, along with related entities, reports the acquisition of 416,667 shares of Disc Medicine at $36 per share through a registered offering.

William Richard White, a director of Disc Medicine, Inc., acquired stock options for 10,000 shares on June 12, 2024.

Director Kevin Bitterman acquired 10,000 stock options in Disc Medicine, Inc. on June 12, 2024.

Director Georges Gemayel acquired 10,000 stock options in Disc Medicine, Inc. on June 12, 2024.

Director Liam Ratcliffe of Disc Medicine, Inc. acquired 10,000 stock options on June 12, 2024, at an exercise price of $38.85.

Director Mark Chin acquired 10,000 stock options in Disc Medicine, Inc. on June 12, 2024.

Director Donald William Nicholson acquired 10,000 stock options in Disc Medicine, Inc. on June 12, 2024.

Mona Ashiya, a director of Disc Medicine, Inc., reported the acquisition of stock options for 10,000 shares on June 12, 2024.

Director William Richard White exercised stock options and sold shares of Disc Medicine, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Director William Richard White exercised stock options and sold shares of Disc Medicine, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Director William Richard White exercised stock options and sold a portion of the acquired shares of Disc Medicine, Inc. under a pre-arranged 10b5-1 trading plan.

William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., reports exercising stock options and disposing of resulting shares on April 10, 2024.

Director Kevin Bitterman sold 26,157 shares of Disc Medicine, Inc. at a weighted average price of $73.50 on March 5, 2024.

Joanne Bryce, CFO of Disc Medicine, Inc., reports the acquisition of stock options and disposal of common stock on January 10, 2024.

Disc Medicine's CEO, John Quisel, acquired shares and stock options in the company on January 10, 2024, according to a Form 4 filing.

Rahul Khara, General Counsel of Disc Medicine, Inc., reports acquisition of common stock and stock options.

Jonathan Yen-Wen Yu, Chief Business Officer of Disc Medicine, Inc., reports acquisition of common stock and stock options.

William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., reports acquisition of shares and stock options.

Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc., reports acquisition of common stock and stock options.